Valuation: China Resources Double-Crane Pharmaceutical Co.,Ltd.

Market Cap 16.56B 2.47B 2.17B 2.04B 1.86B 3.48B 236B 3.5B 24.45B 9.48B 120B 9.26B 9.06B 391B P/E 2026 *
9.37x
P/E 2027 * 8.76x
Enterprise Value 16.56B 2.47B 2.17B 2.04B 1.86B 3.48B 236B 3.5B 24.45B 9.48B 120B 9.26B 9.06B 391B EV / Sales 2026 *
1.45x
EV / Sales 2027 * 1.38x
Free-Float
37.31%
Yield 2026 *
3.18%
Yield 2027 * 3.31%
1 day-0.43%
1 week+1.39%
Current month-0.31%
1 month+2.30%
3 months-3.55%
6 months-9.44%
Current year-12.36%
1 week 15.79
Extreme 15.79
16.19
1 month 15.72
Extreme 15.72
16.33
Current year 15.29
Extreme 15.29
19.08
1 year 15.29
Extreme 15.29
19.77
3 years 14.8
Extreme 14.8
26.15
5 years 11.25
Extreme 11.25
37.44
10 years 10.66
Extreme 10.66
37.44
Manager TitleAgeSince
Director of Finance/CFO 43 18/02/2025
President 45 25/10/2024
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 68 30/05/2006
Director/Board Member 67 12/07/2021
Director/Board Member 60 10/10/2022
Date Insider Type Main position Quantity % Market Cap. Importance
12/21/22 A Buy

Chairman

5,000 0.0005%
12/21/22 A Buy

Director

10,000 0.0010%
12/20/22 A Buy

Director

5,000 0.0005%
Change 5-day change 1-year change 3-year change Capi.($)
-0.43%+1.39%-14.00%-1.54% 2.47B
-1.64%+1.16%+54.09%+109.07% 1,026B
-0.01%+0.71%+52.44%+67.71% 649B
-0.05%+0.98%+19.08%+73.55% 468B
-0.25%+0.19%+36.95%+45.63% 352B
+0.98%+2.91%+20.59%+27.91% 271B
-1.91%+2.42%+10.41%+12.53% 256B
-1.01%+7.90%+41.59%+51.70% 220B
-0.85%+2.50%+32.32%+101.80% 188B
-2.53%-7.47%-32.63%-60.67% 170B
Average -0.26%+1.42%+22.08%+42.77% 360.16B
Weighted average by Cap. +0.44%+1.35%+35.90%+65.87%

Financials

2026 *2027 *
Net sales 11.39B 1.7B 1.49B 1.4B 1.28B 2.39B 163B 2.41B 16.82B 6.52B 82.91B 6.37B 6.24B 269B 11.98B 1.78B 1.57B 1.47B 1.35B 2.52B 171B 2.53B 17.68B 6.86B 87.15B 6.7B 6.55B 283B
Net income 1.78B 265M 232M 218M 200M 373M 25.35B 376M 2.62B 1.02B 12.92B 994M 972M 41.9B 1.9B 283M 248M 234M 214M 399M 27.12B 402M 2.81B 1.09B 13.83B 1.06B 1.04B 44.83B
Net Debt - -
Logo China Resources Double-Crane Pharmaceutical Co.,Ltd.
China Resources Double-Crane Pharmaceutical Co Ltd is a China-based company primarily engaged in the new drug research and development, preparation production, drug sales, and active pharmaceutical ingredients (API) production. The Company operates two segments. The Infusion segment is mainly engaged in the production and sale of infusion products and the provision of services. The Non-Infusion segment is mainly engaged in the production and sale of non-infusion products and the provision of services. The Company's chronic disease business products include compound reserpine triamterene tablets, gliquidone tablets and others. The Company's specialty business products include teniposide injection, busulfan injection and others. The Company's infusion business products include basic infusion, therapeutic infusion, nutritional infusion and other multi-category infusion products. The Company's API business products include valsartan, amlodipine, pregabalin and others.
Employees
13,184
Date Price Change Volume
23/09/26 CN¥16.03 -0.43% 4,611,784
22/09/26 CN¥16.10 -0.12% 5,714,459
21/09/26 CN¥16.12 +1.58% 6,685,100
18/09/26 CN¥15.87 +0.44% 4,507,110
17/09/26 CN¥15.80 -0.06% 3,142,455
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
16.03CNY
Average target price
24.30CNY
Spread / Average Target
+51.59%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600062 Stock